Plasma biomarker analysis in pediatric ARDS: generating future framework from a pilot randomized control trial of methylprednisoloneA framework for identifying plasma biomarkers related to clinical outcomes in pediatric ARDS

• Váldodahkkit: Dai eKimura (Dahkki), Jordy eSaravia (Dahkki), Cynthia R Rovnaghi (Dahkki), Gianfranco Umberto Meduri (Dahkki), Andreas eSchwingshackl (Dahkki), Stephania eCormier (Dahkki), Kanwaljeet J. S. Anand (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2016-03-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Objective: Lung injury activates multiple pro-inflammatory pathways, including neutrophils, epithelial and endothelial injury, and coagulation factors leading to acute respiratory distress syndrome (ARDS). Low-dose methylprednisolone therapy (MPT) improved oxygenation and ventilation in early pediat...